For more than 20 years, Susan Slaugenhaupt, PhD, has been researching a rare disease called Familial Dysautonomia and is closer than ever to finding a cure.
Aiming to improve the lives of millions with type 1 and type 2 diabetes, an MGH researcher is part of an effort to design and test a “bionic pancreas.”
Being part of the Mass General Research Scholars Program has helped Galit Alter, MD, advance her work and attract the attention of major funding agencies.
This story is a repost of Dr. Lecia V. Sequist, MD, MPH “Stigma lingers for deadliest cancer” which was originally published on 10/30/2013 on www.cnn.com. My patient, “Judy,” is one of more than 228,000 Americans this year who will be […]
Harry Orf, PhD, is determined to make it easier for internal and external audiences to fully grasp the breadth and impact of MGH research.
Is it possible to predict someone’s risk of getting type 2 diabetes a dozen years before symptoms appear? Massachusetts General Hospital researcher Robert E. Gerszten, MD, recently told Fox 25 TV Boston about a groundbreaking study he and his colleagues […]
Matt T. Bianchi, MD, PhD, director of Mass General’s Sleep Informatics Laboratory, says how you feel waking up may not be the final word on whether you suffer from Insomnia or sleep apnea.
The results of two new lung cancer studies underscore Massachusetts General Hospital’s pioneering efforts in targeted cancer therapy, a field that could transform the future of care.
Cassandra Kelleher, MD, has received support from the MGH Fund for research to benefit premature newborns who suffer from respiratory distress syndrome (RDS). Premature babies who have difficulty breathing must rely on ventilators for several weeks, even months, after they are born. Dr. Kelleher’s research may soon help premature babies breathe easier, and allow parents to sigh with relief.
A new Avon Foundation for Women grant to the Mass General Cancer Center continues a collaboration to bolster breast cancer research and extend related care.